Aseptic Technologies improves the quality of aseptic processes by providing innovative, user-oriented equipment, devices, and services with state-of-the-art technology for the pharmaceutical industry.
Founded in 2002, Aseptic Technologies develops Fill & Finish solutions. Their core competency lies in the innovation of aseptic filling processes for biopharmaceutical products, including cell and gene therapy products.
As a member of the SKAN Group since 2011, Aseptic Technologies leverages SKAN’s technological excellence in isolator development to deliver integrated Fill & Finish solutions worldwide.
Aseptic Technologies develops, patents, manufactures, and markets devices that guarantee optimal aseptic safety and meet the latest regulatory requirements, while simplifying validation and operational processes in the safest possible way.
The AT-Closed Vial® technology is one of Aseptic Technologies’ most important innovations. It enables the filling of pre-sterilized vials to significantly reduce the risk of batch contamination while simplifying the filling and finishing of drug products.
The company also manufactures other products related to aseptic filling, such as filling kits (AT-Filling Kit™) and aseptic connection systems (AT-Connector™ System), which are used for the transfer of sterile liquids across separating barriers.
Since 2015, SKAN and Aseptic Technologies have joined forces in developing new platforms that combine the respective technologies of both companies, offering integrated solutions that meet the future expectations of the industry.
Aseptic Technologies is certified to ISO 9001 and ISO 15378.